Technical Analysis for TEVA - Teva Pharmaceutical Industries

Grade Last Price % Change Price Change
C 13.32 -0.82% -0.11
TEVA closed down 0.82 percent on Monday, March 18, 2024, on 37 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
6 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Bollinger Band Squeeze Range Contraction -0.82%
Inside Day Range Contraction -0.82%
Gapped Down Weakness -0.82%
20 DMA Support Bullish -1.33%
Bollinger Band Squeeze Range Contraction -1.33%
Bollinger Band Squeeze Range Contraction -2.42%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 9 hours ago
Fell Below Previous Day's Low about 9 hours ago
Fell Below 20 DMA about 9 hours ago
Possible NR7 about 11 hours ago
20 DMA Support about 15 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Teva Pharmaceutical Industries Description

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes pharmaceutical products worldwide. It offers generic pharmaceutical products; and basic chemical entities, as well as specialized product families, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances. The company's principal branded pharmaceutical products comprise Copaxone for multiple sclerosis; Provigil and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Azilect for the treatment of Parkinson's disease; Fentora and Actiq for the treatment of pain in opioid-tolerant adult patients with cancer; Amrix for muscle spasm in acute, painful, and musculoskeletal conditions; ProAir for the treatment of bronchial spasms; Qvar for long-term control of chronic bronchial asthma; and Qnasl Nasal Aerosol for seasonal nasal and year-round nasal allergy symptoms. The company also offers Treanda for the treatment of chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; Tevagrastim/Ratiograstim that stimulate the production of white blood cells; Eporatio, which stimulates the production of red blood cells; Synribo for chronic myeloid leukemia; Plan B One-Step for emergency oral contraception; ParaGard, a non hormonal intrauterine contraceptive; hormone therapies for menopause/perimenopause; Enjuvia for vasomotor symptoms associated with menopause; and therapies for infertility and urinary incontinence. In addition, it produces active pharmaceutical ingredients in the areas of respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants, and muscle relaxants. Further, the company distributes third party products. It has collaborative agreements with Lonza Group Ltd. and OncoGenex Pharmaceuticals, Inc. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Drugs Pain Medication Pharmaceutical Products Lymphoma Parkinson's Disease Opioids Allergy Leukemia Asthma Multiple Sclerosis Hormones MRI Cholesterol Pharmaceutical Industries Active Pharmaceutical Ingredients Fertility Sleep Apnea Treatment Of Parkinson's Disease Chronic Lymphocytic Leukemia Lymphocytic Leukemia Obstructive Sleep Apnea Narcolepsy Immunosuppressants Infertility Birth Control Blood Cells Chemical Entities Generic Pharmaceutical Red Blood Cell Chronic Myeloid Leukemia Teva Pharmaceutical Industries Urinary Incontinence Hot Flash Muscle Spasm Party Products Treatment Of Chronic Lymphocytic Leukemia Bronchial Asthma Contraception Fentanyl Menopause Muscle Relaxants Nasal Allergy Oncogene

Is TEVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.93
52 Week Low 7.085
Average Volume 11,380,516
200-Day Moving Average 9.95
50-Day Moving Average 12.50
20-Day Moving Average 13.35
10-Day Moving Average 13.51
Average True Range 0.35
RSI (14) 55.75
ADX 31.55
+DI 23.53
-DI 17.79
Chandelier Exit (Long, 3 ATRs) 12.88
Chandelier Exit (Short, 3 ATRs) 13.66
Upper Bollinger Bands 13.81
Lower Bollinger Band 12.89
Percent B (%b) 0.47
BandWidth 6.89
MACD Line 0.29
MACD Signal Line 0.36
MACD Histogram -0.0732
Fundamentals Value
Market Cap 14.93 Billion
Num Shares 1.12 Billion
EPS -0.50
Price-to-Earnings (P/E) Ratio -26.64
Price-to-Sales 0.93
Price-to-Book 1.79
PEG Ratio 1.84
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 13.63
Resistance 3 (R3) 13.66 13.59 13.58
Resistance 2 (R2) 13.59 13.51 13.57 13.56
Resistance 1 (R1) 13.45 13.46 13.41 13.42 13.55
Pivot Point 13.38 13.38 13.36 13.36 13.38
Support 1 (S1) 13.24 13.30 13.21 13.22 13.09
Support 2 (S2) 13.17 13.25 13.15 13.08
Support 3 (S3) 13.03 13.17 13.06
Support 4 (S4) 13.01